NASDAQ:STOK | Income Statement | Stoke Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$9.33M$49.5M$25.25M$74.75M-$65.43M$3.81M-$61.62M$0.00-$61.62M-$0.93-$0.9366,017,89566,017,895
2026-03-31$6.23M$39.67M$19.97M$59.65M-$53.42M$3.42M-$50M$0.00-$50M-$0.79-$0.7963,063,50763,063,507
2025-12-31$1.4M$41.7M$21.15M$62.84M-$61.44M$3.51M$0.00-$57.93M-$1.00-$0.97940,372-1,178,497
2025-09-30$10.63M$37.7M$16.03M$53.72M-$43.09M$3.47M-$39.63M-$1.28M-$38.35M-$0.65-$0.6558,611,67758,611,677
2025-06-30$13.82M$25.86M$15.26M$41.12M-$27.3M$3.82M-$23.48M$0.00-$23.48M-$0.40-$0.4058,353,85558,353,855
2025-03-31$158.57M$32.68M$14.65M$47.33M$111.24M$2.92M$114.16M$1.28M$112.88M$1.95$1.9057,862,67459,398,600
2024-12-31$22.61M$23.42M$12.84M$36.27M-$13.65M$3.17M-$10.48M-$0.17-$0.171,017,8681,017,868
2024-09-30$4.89M$22.21M$12.69M$34.9M-$30M$3.57M-$26.43M$0.00-$26.43M-$0.47-$0.4756,341,07456,341,074
2024-06-30$4.83M$21.14M$34.17M-$29.34M$3.65M-$25.7M$0.00-$25.7M-$0.46-$0.4655,765,94855,765,948
2024-03-31$4.22M$22.37M$32.59M-$28.37M$2M-$26.37M$0.00-$26.37M-$0.57-$0.5746,246,88946,246,889
2023-12-31$2.8M$21.78M$32.39M-$29.59M$2.63M-$26.96M-$0.60-$0.60324,875324,875
2023-09-30$3.31M$20.27M$30.54M-$27.23M$2.69M$0.00-$24.54M-$0.55-$0.5544,266,01744,266,017
2023-06-30-$2.48M$20.55M$30.78M-$33.26M$2.61M$0.00-$30.65M-$0.69-$0.6944,188,46444,188,464
2023-03-31$5.15M$19.63M$29.84M-$24.69M$2.15M$0.00-$22.55M-$0.53-$0.5342,536,47442,536,474
2022-12-31$3.27M$21.06M$30.44M-$27.18M$1.52M-$25.66M-$0.65-$0.65180,827180,827
2022-09-30$2.91M$20.11M$30.05M-$27.15M$1.04M$0.00-$26.11M-$0.66-$0.6639,420,31039,420,310
2022-06-30$3.23M$18.36M$28.47M-$25.24M$586,000.00$0.00-$24.65M-$0.63-$0.6339,258,35839,258,358
2022-03-31$3M$18.31M$27.8M-$24.8M$146,000.00$0.00-$24.65M-$0.66-$0.6637,448,30137,448,301
2021-12-31$15.8M$24.53M-$24.53M$78,000.00-$24.45M-$0.67-$1.2832,62263,393
2021-09-30$14.36M$22.68M-$22.68M$86,000.00$0.00-$22.6M-$0.61-$0.6036,759,31936,708,188
2021-06-30$14.1M$22.03M-$22.03M$62,000.00$0.00-$21.97M-$0.60-$0.6036,708,18836,708,188
2021-03-31$9.91M$16.83M-$16.83M$34,000.00$0.00-$16.79M36,643,205
2020-12-31$8.9M$14.59M-$14.59M$25,000.00-$14.56M533,729
2020-09-30$8.11M$13.71M-$13.71M$27,000.00$0.00-$13.68M33,273,597
2020-06-30$7.97M$13.01M-$13.01M$53,000.00$0.00-$12.96M33,054,656
2020-03-31$7.22M$11.74M-$11.74M$696,000.00$0.00-$11.04M32,897,395
2019-12-31$7.09M$11.07M-$11.07M$908,000.00-$10.16M4,979,771
2019-09-30$6.52M$9.84M-$9.84M$1.24M$0.00-$8.6M32,707,647
2019-06-30$6.02M$8.45M-$8.45M$626,000.00$0.00-$7.82M5,083,620
2019-03-31$4.13M$6.32M-$6.32M$580,000.00$0.00-$5.74M833,469
2018-12-31$3M$4.54M-$4.54M-$4.28M16,827
2018-09-30$2.23M$3.32M-$3.32M$0.00-$3.32M698,970
2018-06-30$1.89M$3.01M-$3.01M$0.00-$3.01M691,212
2018-03-31-$1.91M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$184.42M$137.92M$67.09M$205.01M-$20.59M$13.71M$0.00-$6.89M-$0.12-$0.1259,219,18459,219,184
2024-12-31$36.56M$89.13M$48.79M$137.93M-$101.37M$12.39M-$88.98M-$1.65-$1.6554,008,88354,008,883
2023-12-31$8.78M$82.23M$123.55M-$114.77M$10.07M-$104.7M-$2.38-$2.3843,994,86243,994,862
2022-12-31$12.41M$77.84M$116.76M-$104.36M$3.29M-$101.07M-$2.60-$2.6038,897,44238,897,442
2021-12-31$54.17M$86.07M-$86.07M$260,000.00-$85.81M-$2.34-$2.3436,739,26936,739,269
2020-12-31$32.2M$53.04M-$53.04M$801,000.00-$52.24M33,488,456
2019-12-31$23.76M$35.68M-$35.68M$3.35M-$32.33M17,971,443
2018-12-31$8.37M$12.78M-$12.78M$260,000.00-$12.52M709,336

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.